Related references
Note: Only part of the references are listed.Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency
Stylianos Bournazos et al.
CELL (2016)
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
Yaoxing Huang et al.
CELL (2016)
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Jinghe Huang et al.
IMMUNITY (2016)
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Rajeev Gautam et al.
NATURE (2016)
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
Steven W. de Taeye et al.
TRENDS IN IMMUNOLOGY (2016)
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
Cecilia Rademeyer et al.
PLOS PATHOGENS (2016)
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C
Kshitij Wagh et al.
PLOS PATHOGENS (2016)
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay et al.
PLOS PATHOGENS (2016)
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
Xueling Wu et al.
CELL (2015)
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
J. E. Ledgerwood et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
Kevin O. Saunders et al.
JOURNAL OF VIROLOGY (2015)
Ending the HIV-AIDS Pandemic - Follow the Science
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The modern era of HIV-1 vaccine development
John R. Mascola
SCIENCE (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes
Rui Kong et al.
JOURNAL OF VIROLOGY (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Allan deCamp et al.
JOURNAL OF VIROLOGY (2014)
Capacity for Infectious HIV-1 Virion Capture Differs by Envelope Antibody Specificity
Pinghuang Liu et al.
JOURNAL OF VIROLOGY (2014)
Impact of Clade, Geography, and Age of the Epidemic on HIV-1 Neutralization by Antibodies
Peter Hraber et al.
JOURNAL OF VIROLOGY (2014)
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
Justin Pollara et al.
JOURNAL OF VIROLOGY (2014)
Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo
Rebecca S. Rudicell et al.
JOURNAL OF VIROLOGY (2014)
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
Sung-Youl Ko et al.
NATURE (2014)
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
Amarendra Pegu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission
Yegor Voronin et al.
PLOS MEDICINE (2014)
Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study
R. T. Chung et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
Tongqing Zhou et al.
IMMUNITY (2013)
HIV-1 neutralizing antibodies: understanding nature's pathways
John R. Mascola et al.
IMMUNOLOGICAL REVIEWS (2013)
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Andrew T. McGuire et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees
Pinghuang Liu et al.
JOURNAL OF VIROLOGY (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
Barton F. Haynes et al.
NATURE BIOTECHNOLOGY (2012)
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
Anthony P. West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Margaret E. Ackerman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
Guido Ferrari et al.
JOURNAL OF VIROLOGY (2011)
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
Yuxing Li et al.
JOURNAL OF VIROLOGY (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
James R. R. Whittle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Israel Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Subcutaneous immunoglobulin: opportunities and outlook
S. Misbah et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and CHIV-1 primary viruses
Hua-Xin Liao et al.
VIROLOGY (2006)
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies
F Ferrantelli et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial
JR Groothius
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Share Paper
